About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Nikkei Asia reports Japan will provide $125m via a public-private partnership fund to support nuclear fusion and recycling startups.

2026-08-24

Nikkei Asia reports Japan will provide $125m via a public-private partnership fund to support nuclear fusion and recycling startups.

Other News
2026-08-23

The Russian Ministry of Defense stated that Russian troops fired FAB-500 and FAB-1500 bombs at temporary deployment points of Ukrainian troops in the Donetsk and Kharkiv regions.

The Russian Ministry of Defense stated that Russian troops fired FAB-500 and FAB-1500 bombs at temporary deployment points of Ukrainian troops in the Donetsk and Kharkiv regions.
2026-08-23

Politico reports Trump pledged that low-income Americans in states joining him government–drugmaker direct-negotiation plan would quickly gain Medicaid access to costly GLP-1 obesity drugs such as Wegovy and Zepbound. Nine months on, access has narro

Politico reports Trump pledged that low-income Americans in states joining him government–drugmaker direct-negotiation plan would quickly gain Medicaid access to costly GLP-1 obesity drugs such as Wegovy and Zepbound. Nine months on, access has narrowed: only Indiana has publicly backed the plan; several states have stopped reimbursing these drugs for Medicaid patients and others are considering ending coverage. Most states interviewed say they will not participate, citing budget pressure and concerns about the long-term fiscal sustainability of the model, and report other states’ GLP-1 spending has exceeded expectations by several hundred million dollars.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.